当前位置: 首页 >> 检索结果
61. Efficacy and safety of biologic drugs in Still's disease: a systematic review and network meta-analysis of randomized controlled trials.
作者: Berkay Kilic.;Admir Ozturk.;Sejla Karup.;Ervanur Hacioglu.;Serdal Ugurlu.
来源: Rheumatology (Oxford). 2025年64卷1期22-31页
Still's disease is a rare autoinflammatory disorder characterized by systemic inflammation, fever, rash and arthritis. The term 'Still's disease' covers the paediatric subtype systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD), which affects adults. Biologic drugs, including the anti-IL-1 agents anakinra, canakinumab and rilonacept and the IL-6 antagonist tocilizumab, are used in the management of Still's disease.
62. Mental health conditions in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
作者: Xiaotong Liu.;Xinlei Jia.;Xiao Wang.;Ya Bin Wei.;Jia Jia Liu.
来源: Rheumatology (Oxford). 2024年63卷12期3234-3242页
The reported prevalence of mental health conditions (MHCs) in people with systemic lupus erythematosus (SLE) ranges widely. Whether MHCs are associated with increased risk of SLE or the outcomes of the disease is unclear. This study aimed to conduct an umbrella and updated meta-analysis of MHCs in people with SLE and to identify whether MHCs are associated with the risk of SLE or patient outcomes.
63. Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis.
作者: Ivet Etchegaray-Morales.;Claudia Mendoza-Pinto.;Pamela Munguía-Realpozo.;Juan Carlos Solis-Poblano.;Socorro Méndez-Martínez.;Jorge Ayón-Aguilar.;Carlos Abud-Mendoza.;Mario García-Carrasco.;Ricard Cervera.
来源: Rheumatology (Oxford). 2024年63卷8期2047-2055页
To investigate the risk of DM and evaluate the impact of SLE therapies on the risk of developing DM in patients with SLE.
64. Pharmacological interventions for early-stage frozen shoulder: a systematic review and network meta-analysis.
作者: Juan Enrique Berner.;Marios Nicolaides.;Stephen Ali.;Georgios Pafitanis.;Jane Preece.;Sally Hopewell.;Jagdeep Nanchahal.
来源: Rheumatology (Oxford). 2024年63卷12期3221-3233页
To evaluate the efficacy of pharmacological interventions for treating early-stage, pain predominant, adhesive capsulitis, also known as frozen shoulder.
65. The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis.
作者: Stephanie Lembke.;Gary J Macfarlane.;Gareth T Jones.
来源: Rheumatology (Oxford). 2024年63卷12期3211-3220页
Previous attempts to pool prevalence studies in PsA have failed to take account of important methodological differences between studies that may have created biased estimates. The aim of this review is to estimate the prevalence of PsA within the adult general population worldwide, considering potential differences between population-based and health administrative studies separately.
66. Risk of cardiovascular disease decreases over time in psoriatic arthritis but not in spondylarthritis: meta-analysis of longitudinal studies.
作者: Hélène Gouze.;Philippe Aegerter.;Yasmine Gouyette.;Maxime Breban.;Maria Antonietta D'Agostino.
来源: Rheumatology (Oxford). 2024年63卷10期2638-2647页
SpA and PsA represent two frequent inflammatory rheumatic disorders characterized by an increased burden on quality of life due to the association of several comorbidities, especially cardiovascular disease (CVD). The estimated prevalence of CVD ranges from 12 to 19% and differs between the two diseases, however, the incidence of CVD is not completely known. We aimed to systematically review the literature and perform a meta-analysis of controlled observational studies to assess the incidence rate of CVD over time in SpA and PsA.
67. The information required by people with inflammatory arthritis when taking Methotrexate: a mixed-methods systematic review.
作者: Sarah J Logan.;Samantha Hider.;Julie Green.;Sarah J Ryan.
来源: Rheumatology (Oxford). 2024年63卷10期2615-2623页
This mixed-methods systematic review aimed to identify and synthesize knowledge of the characteristics, content, and preferred format of information to support people with inflammatory arthritis (IA) to take MTX.
68. Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials.
To study the therapeutic variations of biologic and targeted synthetic DMARDs (b/tsDMARDs) between genders and across age stages in axial SpA (axSpA) patients through meta-analysis.
69. A systematic review of patient-reported outcome measures in patients with anti-neutrophil cytoplasmic antibody associated vasculitis.
作者: Lauren Floyd.;Muhammad Ahmed.;Adam D Morris.;Andrew C Nixon.;Sandip Mitra.;Ajay Dhaygude.;Christine Rowland.
来源: Rheumatology (Oxford). 2024年63卷10期2624-2637页
ANCA-associated vasculitis (AAV) is associated with significant morbidity, fatigue, pain and poor health-related quality of life (HRQoL). This review aims to assess the comprehensiveness of existing patient reported outcome measures (PROMs) used in AAV and identify associations with poorer HRQoL outcomes.
70. Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis.
作者: Ana Bento da Silva.;Maria Helena Lourenço.;Sofia Ramiro.;Louise Falzon.;Jaime Cunha-Branco.;Désirée van der Heijde.;Robert Landewé.;Alexandre Sepriano.
来源: Rheumatology (Oxford). 2024年63卷11期2923-2937页
The Berlin algorithm was developed to help diagnose axial SpA (axSpA), but new studies suggest some features typical of SpA are less specific than previously assumed. Furthermore, evidence is lacking for other SpA subtypes (e.g. peripheral SpA). We aimed to review the evidence on the performance of SpA features for diagnosing each SpA subtype.
71. Joint involvement in sarcoidosis: systematic review and meta-analysis of prevalence, clinical pattern and outcome.
作者: Terence Yeung.;Adrian Grebowicz.;Tatiana Nevskaya.;Sulman Zahid.;Janet E Pope.
来源: Rheumatology (Oxford). 2024年63卷7期1803-1814页
To characterize joint involvement (JI) in sarcoidosis, a systematic search of MEDLINE, EMBASE and Cochrane Library was conducted from inception to July 2022 for publications reporting its prevalence, pattern, treatment and outcome.
72. Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis.
作者: Lihi Eder.;Sivakami Mylvaganam.;Jordi Pardo Pardo.;Jennifer Petkovic.;Vibeke Strand.;Philip Mease.;Keith Colaco.
来源: Lancet Rheumatol. 2023年5卷12期e716-e727页
Sex-related differences in clinical manifestations and disease outcomes exist in psoriatic arthritis, however, there is limited information on sex-related differences in randomised controlled trials of psoriatic arthritis. We aimed to compare patient characteristics and efficacy and safety of advanced therapies (including biological and targeted synthetic therapies) between male and female patients with psoriatic arthritis participating in randomised controlled trials.
73. Moderators of the effect of therapeutic exercise for knee and hip osteoarthritis: a systematic review and individual participant data meta-analysis.
作者: Melanie A Holden.;Miriam Hattle.;Jos Runhaar.;Richard D Riley.;Emma L Healey.;Jonathan Quicke.;Danielle A van der Windt.;Krysia Dziedzic.;Marienke van Middelkoop.;Danielle Burke.;Nadia Corp.;Amardeep Legha.;Sita Bierma-Zeinstra.;Nadine E Foster.; .; .
来源: Lancet Rheumatol. 2023年5卷7期e386-e400页
Many international clinical guidelines recommend therapeutic exercise as a core treatment for knee and hip osteoarthritis. We aimed to identify individual patient-level moderators of the effect of therapeutic exercise for reducing pain and improving physical function in people with knee osteoarthritis, hip osteoarthritis, or both.
74. Effectiveness of sequential lines of biologic and targeted small-molecule drugs in psoriatic arthritis: a systematic review.
作者: Charlotte E Gollins.;Rosie Vincent.;Caoimhe Fahy.;Neil McHugh.;Mel Brooke.;William Tillett.
来源: Rheumatology (Oxford). 2024年63卷7期1790-1802页
To assess current evidence for effectiveness of sequential lines of biologic and targeted small-molecule disease-modifying anti-rheumatic drugs (b/tsDMARDs) when used beyond first-line for psoriatic arthritis (PsA).
75. Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
作者: Philip J Mease.;Dafna D Gladman.;Joseph F Merola.;Peter Nash.;Stacy Grieve.;Victor Laliman-Khara.;Damon Willems.;Vanessa Taieb.;Adam R Prickett.;Laura C Coates.
来源: Rheumatology (Oxford). 2024年63卷7期1779-1789页
To understand the relative efficacy and safety of bimekizumab, a selective inhibitor of IL-17F in addition to IL-17A, vs other biologic and targeted synthetic DMARDs (b/tsDMARDs) for PsA using network meta-analysis (NMA).
76. Employment of patients with rheumatoid arthritis - a systematic review and meta-analysis.
Patients with rheumatoid arthritis (RA) have difficulties maintaining employment due to the impact of the disease on their work ability. This review aims to investigate the employment rates at different stages of disease and to identify predictors of employment among individuals with RA.
77. Comparative efficacy and safety of bimekizumab in axial spondyloarthritis: a systematic literature review and network meta-analysis.
作者: Atul Deodhar.;Pedro M Machado.;Michael Mørup.;Vanessa Taieb.;Damon Willems.;Michelle Orme.;David Pritchett.;Lianne S Gensler.
来源: Rheumatology (Oxford). 2024年63卷5期1195-1205页
To compare the efficacy and safety of bimekizumab 160 mg every 4 weeks, a selective inhibitor of IL-17F and IL-17A, with those of biologic/targeted synthetic DMARDs (b/tsDMARDs) in non-radiographic axial SpA (nr-axSpA) and AS.
78. Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysis.
作者: Abdallah R Allam.;Mohamed Salah Alhateem.;Abdelrahman Mohamed Mahmoud.
来源: BMC Rheumatol. 2023年7卷1期40页
SLE is an autoimmune disease marked by broad immunological dysregulation and multi-system inflammation. Baricitinib is one of the novel treatments for SLE. We conducted this meta-analysis to evaluate its safety and effectiveness in treating SLE.
79. HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6: a systematic review and meta-analysis.
作者: Stamatia Katelani.;George E Fragoulis.;Athanasios-Dimitrios Bakasis.;Abraham Pouliakis.;Elena Nikiphorou.;Fabiola Atzeni.;Theodoros Androutsakos.
来源: Rheumatology (Oxford). 2023年62卷SI3期SI252-SI259页
The objective of this study was to assess the possibility of HBV reactivation (HBVr) in patients with RA under anti-IL-6 treatment.
80. Addressing the unmet needs of transitional care in juvenile idiopathic arthritis.
作者: Nihal Şahin.;Hafize Emine Sönmez.;Nuray Aktay Ayaz.;Betül Sözeri.
来源: Rheumatology (Oxford). 2024年63卷3期619-629页
We aimed to comprehensively analyse the available literature to identify the unmet requirements in transitional programs tailored specifically for patients diagnosed with JIA.
|